2m 2m 2m 2m 2m 2m 2m
OCUGEN (OCGN)
NASDAQ
$1.38+$0.004 (+0.29%)
Price as of Jun 23, 2026 7:56 PM EDT- $436.7MMarket Cap
- 33.33%1-Year Change
- BiotechnologyIndustry
OCUGEN (OCGN)
$1.38+$0.004 (+0.29%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 4.4M +8.83% | 4.1M -32.82% | 6.0M N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 4.4M +8.83% | 4.1M -32.82% | 6.0M N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -39.8M +23.73% | -32.1M -18.82% | -39.6M -20.47% | -49.8M +41.73% | |
Depreciation and Amortization Expense | 2.4M +21.39% | 2.0M +179.55% | 704,000 +46.67% | 480,000 +109.61% | |
Total Operating Expenses | 67.3M +14.48% | 58.8M -17.82% | 71.6M -15.67% | 84.9M +46.25% | |
Operating Profit | -62.9M +14.90% | -54.8M -16.44% | -65.5M -22.78% | -84.9M +46.25% | |
Interest Income | 922,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 922,000 N/A | 0 N/A | 0 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | -4.9M -801.28% | 703,000 -71.34% | 2.5M -30.25% | 3.5M +1,004.11% | |
Income before Taxes | -67.8M +25.62% | -54.0M -17.58% | -65.5M -19.45% | -81.4M +39.26% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 +100.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -67.8M +25.52% | -54.1M -14.31% | -63.1M -22.46% | -81.4M +39.38% | |
Net Income from Continuing Operations Applicable to Common | -67.8M +25.62% | -54.0M -14.38% | -63.1M -22.46% | -81.4M +39.38% | |
Basic EPS and Net Income | -0.23 +15.00% | -0.20 -23.08% | -0.26 -31.58% | -0.38 +26.67% | |
Diluted EPS and Net Income | -0.23 +15.00% | -0.20 -23.08% | -0.26 -31.58% | -0.38 +26.67% | |
Basic Weighted Average Shares | 300.2M +10.77% | 271.0M +10.91% | 244.3M +13.85% | 214.6M +10.04% | |
Diluted Weighted Average Shares | 300.2M +10.77% | 271.0M +10.91% | 244.3M +13.85% | 214.6M +10.04% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 18.6M -68.26% | 58.5M +48.28% | 39.5M -49.12% | 77.6M -18.32% | |
Short-Term Investments | N/A N/A | N/A N/A | 0 -100.00% | 13.4M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 18.6M -68.26% | 58.5M +48.28% | 39.5M -56.60% | 90.9M -4.24% | |
Total Current Assets | 24.3M -60.54% | 61.7M +43.54% | 43.0M -56.37% | 98.5M -4.05% | |
Accumulated Depreciation | 5.5M +74.46% | 3.2M +156.91% | 1.2M +98.07% | 621,000 +66.04% | |
Property and Plant and Equipment and Net | 14.4M -13.06% | 16.6M -4.26% | 17.3M +185.64% | 6.1M +420.02% | |
Total Long-Term Assets | 4.5M +14.59% | 3.9M -9.03% | 4.3M +4.87% | 4.1M +127.06% | |
Total Assets | 43.5M -47.22% | 82.4M +27.72% | 64.5M -40.58% | 108.6M +2.71% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.3M -5.73% | 1.3M +3.92% | 1.3M N/A | N/A N/A | |
Total Current Liabilities | 23.0M +6.74% | 21.6M +26.33% | 17.1M -7.43% | 18.5M +163.71% | |
Total Long-Term Debt | 27.5M +0.72% | 27.3M +876.61% | 2.8M +22.32% | 2.3M +33.70% | |
Total Long-Term Liabilities | 32.6M +4.54% | 31.2M +352.89% | 6.9M +12.65% | 6.1M +107.95% | |
Total Liabilities | 55.7M +5.44% | 52.8M +120.20% | 24.0M -2.43% | 24.6M +147.21% | |
Retained Earnings | -408.1M +19.94% | -340.2M +18.89% | -286.2M +34.34% | -213.0M +61.79% | |
Total Stockholders Equity | -12.2M -141.06% | 29.6M -26.95% | 40.6M -51.74% | 84.1M -12.28% | |
Total Shares Outstanding | 312.4M +7.21% | 291.4M +13.56% | 256.6M +15.78% | 221.6M +11.14% | |
Cash Flow | |||||
Cash from Operating Activities | -57.0M +35.17% | -42.1M -32.09% | -62.1M +3.29% | -60.1M +25.32% | |
Capital Expenditures | 185,000 -94.53% | 3.4M -67.69% | 10.5M +135.05% | 4.5M +374.65% | |
Cash from Investing Activities | -311,000 -90.81% | -3.4M -210.01% | 3.1M +118.14% | -17.0M +834.31% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 17.3M -73.28% | 64.9M +210.61% | 20.9M -64.89% | 59.5M -50.72% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -1,425.70% +5.58% | -1,350.36% +24.38% | -1,085.67% N/A | N/A N/A | |
Return on Assets | -107.73% +46.47% | -73.55% +0.96% | -72.85% -4.01% | -75.89% -13.44% | |
Return on Equity | -776.89% +404.45% | -154.01% +52.13% | -101.24% +11.92% | -90.46% -9.05% | |
Revenue Growth | 8.83% +126.90% | -32.82% N/A | N/A N/A | N/A N/A | |
Current Ratio | 1.06 -63.03% | 2.86 +13.63% | 2.51 -52.87% | 5.34 -63.61% | |
Cash Ratio | 0.81 -70.27% | 2.71 +17.38% | 2.31 -45.04% | 4.20 -69.03% | |
Debt-to-Equity Ratio | -2.37 -344.58% | 0.97 +862.79% | 0.10 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.66 +90.22% | 0.35 +451.19% | 0.06 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow